Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 4.70% | 35.42 | 0.9% | $1191.39m | |
| JNJ | Johnson & Johnson | 2.07% | 145.32 | 0.7% | $1036.46m | |
| BMY | Bristol-Myers Squibb Co. | 1.41% | 58.24 | 1.0% | $935.02m | |
| MRK | Merck & Co., Inc. | 1.93% | 78.21 | 0.7% | $802.87m | |
| ABBV | AbbVie, Inc. | 2.02% | 98.79 | 1.9% | $740.36m | |
| LLY | Eli Lilly & Co. | 1.28% | 165.46 | 1.1% | $650.06m | |
| AZN | AstraZeneca Plc | 0.83% | 54.21 | 1.2% | $290.91m | |
| RPRX | Royalty Pharma Plc | -3.97% | 45.75 | 0.1% | $195.68m | |
| NVS | Novartis AG | 0.25% | 87.23 | 0.2% | $143.67m | |
| RGEN | Repligen Corp. | 1.94% | 128.58 | 7.1% | $117.58m | |
| GSK | GlaxoSmithKline Plc | 1.35% | 40.45 | 0.2% | $111.37m | |
| NVO | Novo Nordisk A/S | 0.93% | 66.05 | 0.1% | $89.30m | |
| RETA | Reata Pharmaceuticals, Inc. | 1.26% | 156.35 | 3.4% | $80.43m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.15% | 74.25 | 0.0% | $67.66m | |
| SNY | Sanofi | 2.21% | 51.39 | 0.2% | $65.15m |
Company Profile
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of a broad range of proprietary chimeric antigen receptor engineered T cell (CAR T) immunotherapies and gene therapies. It develops CAR T and CRISPR/Cas9-enhanced CAR T therapies across multiple cancers, as well as lentiviral gene therapy for XSCID. The firm's products include MB-101 IL13Ra2-specific CAR, MB-102 CD123 CAR, MB-103 HER2 CAR, MB-104 CS1 CAR, MB-105 PSCA CAR, MB-106 CD20 CAR, MB-107 XSCID Gene Therapy and Oncolytic Virus (C134). The company was founded on March 13, 2015 and is headquartered in Worcester, MA.